Rutgers and Stanford scientists develop novel way to inject healthy human nerve cells into the brain
Scientists at Rutgers and Stanford universities have created a new technology that could someday help treat Parkinson’s disease and other devastating brain-related conditions that affect millions of people.
“If you can transplant cells in a way that mimics how these cells are already configured in the brain, then you’re one step closer to getting the brain to communicate with the cells that you’re now transplanting,” said Moghe, research director for the School of Engineering/Health Sciences Partnerships at Rutgers. “In this work, we’ve done that by providing cues for neurons to rapidly network in 3-D.”
Neurons, or nerve cells, are critical for human health and functioning. Human brains have about 100 billion neurons, which serve as messengers that transmit signals from the body to the brain and vice versa.
Moghe said a 3-D scaffold, developed by the scientists, consists of tiny polymer fibers. Hundreds of neurons attach to the fibers and branch out, sending their signals. Scaffolds are about 100 micrometers wide – roughly the width of a human hair.
“We take a whole bunch of these islands and then we inject them into the brain of the mouse,” he said. “These neurons that are transplanted into the brain actually survived quite miraculously well. In fact, they survived so much better than the gold standard in the field.”
Indeed, the scaffold technology results in a 100-fold increase in cell survival over other methods, Moghe said.
And that may eventually help people suffering from Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, Alzheimer’s disease, spinal cord and traumatic brain injuries, and concussions, he said.
These diseases and conditions often arise from the loss of brain cells. Parkinson’s disease, for example, is caused by the loss of brain cells that produce dopamine, a key neurotransmitter. Brain cell loss can lead to trembling in the hands, arms, legs, jaw and face; rigidity, or stiffness of the limbs and trunk; slowness of movement; and impaired balance and coordination, according to the National Institutes of Health.
The next step would be to further improve the scaffold biomaterials, allowing scientists to increase the number of implanted neurons in the brain. “The more neurons we can transplant, the more therapeutic benefits you can bring to the disease,” Moghe said. “We want to try to stuff as many neurons as we can in as little space as we can.”
The idea is to “create a very dense circuitry of neurons that is not only highly functioning but also better controlled,” he said, adding that testing of mice with Parkinson’s disease is underway to see if they improve or recover from the illness.
Eventually, with continued progress, the researchers could perform studies in people. Moghe estimated that it would take 10 to 20 years to test the technology in humans.
Developing the scaffold technology and reprogramming the stem cells in the scaffolds was “very hard team work,” he said. “It took many years to get here, so there was a lot of sweat and toil.”
Learn more: Future Brain Therapies for Parkinson’s Possible with Stem Cell Bioengineering Innovation
The Latest on: Stem cell bioengineering
[google_news title=”” keyword=”stem cell bioengineering” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stem cell bioengineering
- What It'll Take to Create 21st-Century Mammoths, Dodos, and Thylacineson April 27, 2024 at 8:16 am
We don’t fully understand how to create an artificial placenta at the moment. We don’t really understand the intricacies of the developmental process. This is all information that we will learn along ...
- New experimental evidence unlocks a puzzle in vascular tissue engineeringon April 25, 2024 at 9:25 am
Angiogenesis is a process of forming hierarchical vascular networks in living tissues. Its complexity makes the controlled generation of blood vessels in laboratory conditions a highly challenging ...
- How mRNA Is Rewriting the Rules of Cancer Treatmenton April 24, 2024 at 2:24 pm
MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments. What if training your immune system to ...
- Single-cell nanobiopsy explores how brain cancer cells adapt to resist treatmenton April 22, 2024 at 4:59 pm
Almost all tumours recur after treatment, as surviving cells transform into more resilient forms over time to resist further therapies. To address this challenge, scientists at the University of Leeds ...
- Scientists harness ultrasound for drug delivery and tissue implantationon April 22, 2024 at 2:03 pm
Research presents an advance in drug delivery and tissue implantation assisted by ultrasound, developed by researchers from the Technion Faculty of Biomedical Engineering. The work is published in the ...
- If It Rights the Ship, Harvard Can Inform a New Renaissanceon April 21, 2024 at 9:04 pm
The people who help earn its reputation, and the people who live off it. With a combination of grace and grit, we can all be the former.
- Engineered peptides open new avenue for immunotherapy drug developmenton April 19, 2024 at 2:00 am
In a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using ...
- RNA's hidden potential: New study unveils its role in early life and future bioengineeringon April 18, 2024 at 1:21 pm
The beginning of life on Earth and its evolution over billions of years continue to intrigue researchers worldwide. The central dogma or the directional flow of genetic information from a deoxyribose ...
- Microscopes reveal a frozen moment in cellular time—a new method records cells as they workon April 14, 2024 at 9:50 am
Researchers at Princeton and Rockefeller University have found a new way to study cellular communication, recording interactions between cells as they work in a living organism and unlocking new ways ...
- New insights on B cells: Researchers explore building better antibodies and curbing autoimmune diseaseson April 12, 2024 at 10:06 am
As described in Nature Biomedical Engineering in March, they performed CRISPR gene editing on B cells in mice, replacing genes for antibody light and heavy chains with their human counterparts at ...
via Bing News